McNeil's Motrin IB Sales Up 19% Through Mid-September - IRI
This article was originally published in The Tan Sheet
Executive Summary
McNeil Consumer Product's Motrin IB analgesic continued to grow substantially into the third quarter as branded market leader Tylenol lost ground, based on Information Resources, Inc. (Chicago) data for the 52 weeks ended Sept. 13.